Apimeds Pharmaceuticals US, Inc. - APUS
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 19
Latest filed: Mar 26, 2026
| Form | Count |
|---|---|
| 8-K | 7 |
| 4 | 6 |
| SCHEDULE 13D/A | 2 |
| 8-K/A | 2 |
| SCHEDULE 13G | 1 |
| 4/A | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Mar 26, 2026 | 8-K | Mar 20, 2026 | 0001213900-26-034786 | View |
| Mar 25, 2026 | 8-K | Mar 20, 2026 | 0001213900-26-033832 | View |
| Mar 20, 2026 | SCHEDULE 13D/A | — | 0001213900-26-032480 | View |
| Mar 16, 2026 | 8-K | Mar 16, 2026 | 0001213900-26-028332 | View |
| Feb 17, 2026 | 8-K/A | Dec 01, 2025 | 0001213900-26-017323 | View |
| Feb 11, 2026 | SCHEDULE 13G | — | 0001493152-26-006136 | View |
| Jan 26, 2026 | SCHEDULE 13D/A | — | 0001213900-26-007438 | View |
| Jan 02, 2026 | 8-K | Dec 30, 2025 | 0001213900-26-000464 | View |
| Dec 10, 2025 | 8-K/A | Dec 01, 2025 | 0001213900-25-119893 | View |
| Dec 10, 2025 | 8-K | Dec 05, 2025 | 0001213900-25-119894 | View |
| Dec 02, 2025 | 8-K | Dec 01, 2025 | 0001213900-25-117173 | View |
| Nov 21, 2025 | 4/A | May 12, 2024 | 0002057997-25-000002 | View |
| Nov 18, 2025 | 8-K | Nov 13, 2025 | 0001213900-25-112184 | View |
| Nov 13, 2025 | 4 | Nov 11, 2025 | 0001679971-25-000008 | View |
| Nov 13, 2025 | 4 | Nov 11, 2025 | 0001573840-25-000003 | View |
| Nov 13, 2025 | 4 | Nov 11, 2025 | 0002041972-25-000004 | View |
| Nov 13, 2025 | 4 | Nov 11, 2025 | 0002041300-25-000003 | View |
| Nov 13, 2025 | 4 | Nov 11, 2025 | 0002040378-25-000004 | View |
| Oct 24, 2025 | 4 | Oct 15, 2025 | 0001679971-25-000007 | View |